April 27, 2004
1 min read
Save

Video-ICG helps diagnose macular disease, clinician says

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

FORT LAUDERDALE, Fla. – Digital indocyanine green video angiography can enhance the characterization of macular lesions and aid physicians in diagnosing a variety of macular diseases, said Robert P. Murphy, MD, here at the International Society of Imaging in the Eye meeting.

Dr. Murphy evaluated the usefulness of dynamic digital indocyanine green video angiography (V-ICG) during the retinal arteriole filling phase as a complement to fluorescein angiography in diagnosing macular disease.

Dr. Murphy suggested that using V-ICG will help physicians correctly diagnose a variety of macular diseases and avoid damaging and time-consuming therapies that are not tailored to the diagnosis.

He described a study in which fluorescein angiography and V-ICG were performed in patients with a variety of macular diseases, including macular degeneration with choroidal neovascularization, branch retinal vein occlusion, central retinal vein occlusion, branch retinal artery occlusion, parafoveal telangiectasia with CNV and CNV associated with angioid streaks.

“Fluorescein angiography can detect macular disease, but utilizing the video angiography brings the diagnosis more clearly, more quickly and more abruptly. Most cases of occult choroidal neovascularization are actually classic CNV. With the video angiography there is no guesswork,” Dr. Murphy said.